STING agonist-18

• UNSPSC Description:

  STING agonist-18 (compound 1a) can be used for synthesis of antibody-drug conjugates (ADCs), such Trastuzumab (HY-P9907) conjugate[1].

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/sting-agonist-18.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=CC(C)=NN1CC)NC2=NC3=CC(C(N)=O)=CC(OC)=C3N2C/C=C/CN4C5=C(OCCCN)C=C(C(N)=O)C=C5N=C4NC(C6=CC(C)=NN6CC)=O

• Molecular Weight:

  779.85

• References & Citations:

  [1]Jeremy R. Duvall, et al. Antibody drug conjugates comprising sting agonists. WO2021202984A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2138299-68-8